Is Telix Pharmaceuticals Limited (TLX) a Buy, Sell, or Hold?
NASDAQ : TLX
Telix Pharmaceuticals Limited
$11.29 USD
$0.27 (2.45%)
- Volume
- 56.58K
- Average Volume
- 185.39K
- Market Capitalization
- $3.82B
- P/E Ratio
- -486.29
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $16.94
- Year Low
- $6.28
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.43
| Date | EPS Estimated | Time | Revenue | Revenue Estimated |
|---|---|---|---|---|
| 2026-08-20 | 0.02 | After Market Close | -$ | $464.88M |
| 2026-02-19 | 0.03 | After Market Close | $413.4M | $418.49M |
| 2025-08-20 | 0.13 | After Market Close | $390.36M | $390.49M |
| 2025-02-20 | 0.09 | After Market Close | $267.24M | $135.06M |
| 2024-08-22 | 0.09 | After Market Close | $246.48M | $237.81M |
| 2024-05-17 | After Market Close | $116.82M | $112.6M | |
| 2024-02-22 | 0.05 | After Market Close | $184.81M | $182M |
| 2023-08-23 | 0.04 | After Market Close | $142.14M | $146.9M |
| 2023-02-27 | -0.05 | After Market Close | $90.06M | $86.96M |
| 2022-08-17 | -0.08 | After Market Close | $16.7M | $20.37M |
| 2022-02-23 | -0.05 | After Market Close | $1.99M | $2.39M |